|
Teva Pharmaceutical Industries Limited - Comparative Business Analysis Snapshot
Business Description
Teva Pharmaceutical Industries Limited. The Group's principal activities are to involve in the development, manufacturing, marketing and distribution of Pharmaceuticals and Active Pharmaceutical Ingredients. The Group operates under two segments: Pharmaceutical and API. Under Pharmaceutical, the Group involves in the development, production, marketing and distribution of drugs in various dosages and forms, in most areas of medicinal treatment and disposable hospital supplies. Under API, the Group involves in the development, production, marketing and distribution of API for the pharmaceutical industry. The Group manufactures solid dosage forms, injectables, liquids, semi-solids and inhalers. The products of the Group include Copaxone and Azilect. The Group operates with 34 dosage pharmaceutical plants in North America, Latin America, Europe, Israel and China. The majority of the Group's sales are in North America and Western Europe. It acquired Barr in 2008.
Competitor Analysis
This analysis compares Teva Pharmaceutical Industries Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
